Briefing: Gene edit makes probiotic safer for immunocompromised patients
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
Briefing: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial
Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials.
Briefing: Men who brought explosives to NYC protest cited Islamic State as inspiration, complaint says
Strategic angle: Two individuals arrested for carrying explosives at a protest in New York City reportedly cited the Islamic State as their motivation.
Briefing: CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Strategic angle: A groundbreaking approach using CRISPR technology shows promise in treating heart failure by enhancing mitochondrial function.
Briefing: Unlocking the hidden pocket on a billion‑dollar drug target
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Briefing: Key protein SYFO2 enables 'self-fertilization' of leguminous plants
Strategic angle: Research reveals how SYFO2 protein facilitates self-fertilization in legumes, enhancing agricultural efficiency.
Briefing: ‘Cash Apples’ is giving away $500,000 to people who click on trees in a web browser
Strategic angle: Want to make real money just by clicking on virtual trees? Starting today, residents of the United States can begin an online hunt for golden apples.
Briefing: The ER Staffing Conflict and No Facility Fee for a Marmot
Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Briefing: A setback for Roche’s breast cancer drug
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Briefing: Fresh turmoil at the FDA with Prasad’s exit
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Briefing: Talkspace to be acquired for $835 million by mental health services giant
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Briefing: Health tech company says it will dive into Medicare’s new chronic care experiment
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.
Evaluating the Risks of AI Chatbots for Medical Advice
The launch of ChatGPT Health by OpenAI prompts a critical examination of the risks associated with AI-driven health consultations.
Strategic view: Health advice from chatbots: what to know before using them
Strategic implications in focus: Following OpenAI's recent ChatGPT Health launch, here are key points to consider before relying on AI chatbots for medical guidance.
Limited Impact of CMS's New Risk-Adjustment Model on Medicare Advantage Benefits
A study in Health Affairs indicates that the new risk-adjustment model from CMS has not substantially altered Medicare Advantage benefits for the 2024-25 period.
Strategic view: Health Care Workforce, Medicare, And More
Strategic implications in focus: An overview of critical issues in health care as discussed in Health Affairs.
Strategic view: Practice Pattern Changes After Adoption Of Diagnostic AI Tool Used In Conjunction With Cardiac Imaging
Strategic implications in focus: Health Affairs, Volume 45, Issue 3, Page 238-245, March 2026.
Disenrollment Rates for Medicare Advantage Beneficiaries Raise Concerns
A recent study indicates that disenrollment rates for Medicare Advantage beneficiaries have tripled between 2017 and 2022, prompting questions about plan stability.
SSDI Beneficiaries Face Increased Mortality Rates During Medicare Waiting Period
A study spanning 2000 to 2021 reveals concerning mortality trends among SSDI beneficiaries awaiting Medicare, highlighting systemic healthcare risks.
Staffing Mandates in Nursing Homes: Analyzing Financial and Operational Outcomes
An examination of nursing home staffing mandates from 2010 to 2023 shows increased staffing levels with negligible financial impact and no notable rise in closures.